131 related articles for article (PubMed ID: 2874461)
21. The effect of castration, thyroidectomy and haloperidol upon the turnover rates of dopamine and norepinephrine and the kinetic properties of tyrosine hydroxylase in discrete hypothalamic nuclei of the male rat.
Kizer JS; Humm J; Nicholson G; Greeley G; Youngblood W
Brain Res; 1978 May; 146(1):95-107. PubMed ID: 25696
[TBL] [Abstract][Full Text] [Related]
22. The effect of neuroleptics on brain tyrosine hydroxylase.
Rayevsky KS; Mineyeva MF; Kudrin VS
Ann Ist Super Sanita; 1978; 14(1):89-96. PubMed ID: 40504
[TBL] [Abstract][Full Text] [Related]
23. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
Lerner P; Nosé P; Gordon EK; Lovenberg W
Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration.
Austin MC; Cottingham SL; Paul SM; Crawley JN
Synapse; 1990; 6(4):351-7. PubMed ID: 1705056
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine.
Pasinetti GM; Morgan DG; Johnson SA; Millar SL; Finch CE
J Neurochem; 1990 Nov; 55(5):1793-9. PubMed ID: 1976760
[TBL] [Abstract][Full Text] [Related]
26. Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats.
Steinpreis RE; Salamone JD
Pharmacol Biochem Behav; 1993 Oct; 46(2):405-9. PubMed ID: 8265695
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine hydroxylase and dopamine beta-hydroxylase inductions evoked by reserpine in the superior cervical ganglion of developing eu- and hypothyroid rats.
de Lonlay A; Blouquit MF; Valens M; Chami N; Edwards DA; Gripois D
J Auton Nerv Syst; 1991 Oct; 36(1):33-8. PubMed ID: 1684370
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine hydroxylase activity in noradrenergic neurons of the locus coeruleus after reserpine administration: sequential increase in cell bodies and nerve terminals.
Zigmond RE
J Neurochem; 1979 Jan; 32(1):23-9. PubMed ID: 32230
[No Abstract] [Full Text] [Related]
29. Source and physiological significance of plasma 3,4-dihydroxyphenylalanine in the rat.
Eisenhofer G; Goldstein DS; Ropchak TG; Kopin IJ
J Neurochem; 1988 Oct; 51(4):1204-13. PubMed ID: 2901461
[TBL] [Abstract][Full Text] [Related]
30. Cyclic AMP content and regulation of tyrosine-3-mono-oxygenase in rat striatum.
Zivkovic B; Guidotti A; Costa E
J Cyclic Nucleotide Res; 1976; 2(1):1-10. PubMed ID: 5470
[TBL] [Abstract][Full Text] [Related]
31. Direct transfer into nitrocellulose and quantitative radioautographic anatomical determination of brain tyrosine hydroxylase protein concentration.
Weissmann D; Labatut R; Richard F; Rousset C; Pujol JF
J Neurochem; 1989 Sep; 53(3):793-9. PubMed ID: 2569505
[TBL] [Abstract][Full Text] [Related]
32. Increase of tyrosine hydroxylase activity after reserpine: evidence for the selective response of noradrenergic neurons.
Sorimachi M
Brain Res; 1975 Dec; 99(2):400-4. PubMed ID: 241464
[No Abstract] [Full Text] [Related]
33. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
Berry SA; Gudelsky GA
J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
[TBL] [Abstract][Full Text] [Related]
34. Detection and regulation of tyrosine hydroxylase mRNA in catecholaminergic terminal fields: possible axonal compartmentalization.
Melia KR; Trembleau A; Oddi R; Sanna PP; Bloom FE
Exp Neurol; 1994 Dec; 130(2):394-406. PubMed ID: 7532593
[TBL] [Abstract][Full Text] [Related]
35. Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity.
Gale K; Moroni F; Kumakura K; Guidotti A
Neuropharmacology; 1979 Apr; 18(4):427-30. PubMed ID: 36574
[No Abstract] [Full Text] [Related]
36. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM
Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452
[TBL] [Abstract][Full Text] [Related]
37. Increased tyrosine hydroxylase activity in frontal cortex and cerebellum after reserpine.
Black IB
Brain Res; 1975 Sep; 95(1):170-6. PubMed ID: 239785
[No Abstract] [Full Text] [Related]
38. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
Besson MJ; Cheramy A; Gauchy C; Musacchio J
Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
[No Abstract] [Full Text] [Related]
39. Differential effects of the intraventricular administration of 6-hydroxydopamine on the induction of type II beta-tubulin and tyrosine hydroxylase mRNA in the locus coeruleus of the aging Fischer 344 rat.
Unnerstall JR; Long MM
J Comp Neurol; 1996 Jan; 364(2):363-81. PubMed ID: 8788255
[TBL] [Abstract][Full Text] [Related]
40. Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain.
Bullard WP; Guthrie PB; Russo PV; Mandell AJ
J Pharmacol Exp Ther; 1978 Jul; 206(1):4-20. PubMed ID: 660556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
